BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32087340)

  • 21. Comparing Smoking Cessation Interventions among Underserved Patients Referred for Lung Cancer Screening: A Pragmatic Trial Protocol.
    Kohn R; Vachani A; Small D; Stephens-Shields AJ; Sheu D; Madden VL; Bayes BA; Chowdhury M; Friday S; Kim J; Gould MK; Ismail MH; Creekmur B; Facktor MA; Collins C; Blessing KK; Neslund-Dudas CM; Simoff MJ; Alleman ER; Epstein LH; Horst MA; Scott ME; Volpp KG; Halpern SD; Hart JL;
    Ann Am Thorac Soc; 2022 Feb; 19(2):303-314. PubMed ID: 34384042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient navigation to promote lung cancer screening in a community health center for people experiencing homelessness: Protocol for a pragmatic randomized controlled trial.
    Baggett TP; Barbosa Teixeira J; Rodriguez EC; Anandakugan N; Sporn N; Chang Y; Percac-Lima S; Park ER; Rigotti NA
    Contemp Clin Trials; 2022 Feb; 113():106666. PubMed ID: 34971796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking cessation services and shared decision-making practices among lung cancer screening facilities: A cross-sectional study.
    Lowenstein LM; Nishi SPE; Lopez-Olivo MA; Crocker LC; Choi N; Kim B; Shih YT; Volk RJ
    Cancer; 2022 May; 128(10):1967-1975. PubMed ID: 35157302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context.
    Quinn-Scoggins HD; Murray RL; Quaife SL; Smith P; Brain KE; Callister MEJ; Baldwin DR; Britton J; Crosbie PAJ; Thorley R; McCutchan GM
    BMC Pulm Med; 2022 Dec; 22(1):478. PubMed ID: 36522781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol for a randomized controlled trial of the Enhanced Smoking Cessation Approach to Promote Empowerment (ESCAPE) digitalized intervention to promote lung health in high-risk individuals who smoke.
    Cooley ME; Castaldi PJ; Mazzola E; Blazey MU; Nayak MM; Healey MJ; Lathan CS; Borondy-Kitts A; DeMarco RF; Kim SS
    Contemp Clin Trials; 2023 Jan; 124():107005. PubMed ID: 36396069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study.
    Kanodra NM; Pope C; Halbert CH; Silvestri GA; Rice LJ; Tanner NT
    Ann Am Thorac Soc; 2016 Nov; 13(11):1977-1982. PubMed ID: 27676369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial.
    Rojewski AM; Tanner NT; Dai L; Ravenel JG; Gebregziabher M; Silvestri GA; Toll BA
    Chest; 2018 Jul; 154(1):110-118. PubMed ID: 29793736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial.
    Sinclair L; McFadden M; Tilbrook H; Mitchell A; Keding A; Watson J; Bauld L; Kee F; Torgerson D; Hewitt C; McKell J; Hoddinott P; Harris FM; Uny I; Boyd K; McMeekin N; Ussher M; Tappin DM;
    Trials; 2020 Feb; 21(1):183. PubMed ID: 32059684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examination of Chronic Smoking Behavior and Eligibility for Low-Dose Computed Tomography for Lung Cancer Screening Among Older Chinese Male Smokers.
    Li CC; Matthews AK; Dong X
    J Gerontol A Biol Sci Med Sci; 2017 Jul; 72(suppl_1):S22-S25. PubMed ID: 28575258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement.
    Kathuria H; Detterbeck FC; Fathi JT; Fennig K; Gould MK; Jolicoeur DG; Land SR; Massetti GM; Mazzone PJ; Silvestri GA; Slatore CG; Smith RA; Vachani A; Zeliadt SB; Wiener RS;
    Am J Respir Crit Care Med; 2017 Nov; 196(9):1202-1212. PubMed ID: 29090963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pragmatic Application of the RE-AIM Framework to Evaluate the Implementation of Tobacco Cessation Programs Within NCI-Designated Cancer Centers.
    D'Angelo H; Ramsey AT; Rolland B; Chen LS; Bernstein SL; Fucito LM; Webb Hooper M; Adsit R; Pauk D; Rosenblum MS; Cinciripini PM; Joseph A; Ostroff JS; Warren GW; Fiore MC; Baker TB
    Front Public Health; 2020; 8():221. PubMed ID: 32596200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.
    Rendle KA; Burnett-Hartman AN; Neslund-Dudas C; Greenlee RT; Honda S; Elston Lafata J; Marcus PM; Cooley ME; Vachani A; Meza R; Oshiro C; Simoff MJ; Schnall MD; Beaber EF; Doria-Rose VP; Doubeni CA; Ritzwoller DP
    Cancer Prev Res (Phila); 2020 Feb; 13(2):129-136. PubMed ID: 31871221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A stepped-wedge randomized trial protocol of a community intervention for increasing lung screening through engaging primary care providers (I-STEP).
    Salazar AS; Sekhon S; Rohatgi KW; Nuako A; Liu J; Harriss C; Brennan E; LaBeau D; Abdalla I; Schulze C; Muenks J; Overlot D; Higgins JA; Jones LS; Swick C; Goings S; Badiu J; Walker J; Colditz GA; James AS
    Contemp Clin Trials; 2020 Apr; 91():105991. PubMed ID: 32184197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capitalizing on a teachable moment: Development of a targeted self-help smoking cessation intervention for patients receiving lung cancer screening.
    Meltzer LR; Unrod M; Simmons VN; Brandon KO; PiƱeiro B; Palmer AM; Brandon TH
    Lung Cancer; 2019 Apr; 130():121-127. PubMed ID: 30885332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.
    Tanner NT; Kanodra NM; Gebregziabher M; Payne E; Halbert CH; Warren GW; Egede LE; Silvestri GA
    Am J Respir Crit Care Med; 2016 Mar; 193(5):534-41. PubMed ID: 26502000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study rationale and design of the PEOPLHE trial.
    Milanese G; Silva M; Ledda RE; Iezzi E; Bortolotto C; Mauro LA; Valentini A; Reali L; Bottinelli OM; Ilardi A; Basile A; Palmucci S; Preda L; Sverzellati N;
    Radiol Med; 2024 Mar; 129(3):411-419. PubMed ID: 38319494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.
    Lancaster HL; Heuvelmans MA; Oudkerk M
    J Intern Med; 2022 Jul; 292(1):68-80. PubMed ID: 35253286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can a national lung cancer screening program in combination with smoking cessation policies cause an early decrease in tobacco deaths in Italy?
    Carreras G; Gorini G; Paci E
    Cancer Prev Res (Phila); 2012 Jun; 5(6):874-82. PubMed ID: 22525583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementing lung cancer screening: the US experience.
    Aberle DR
    Clin Radiol; 2017 May; 72(5):401-406. PubMed ID: 28069160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.